Clinical trials open to people under 18
(55 trials open to new patients)

• Acute Lymphoblastic Leukemia (1 open to new patients)
• Adverse Childhood Experiences (1 open to new patients)
• Alopecia (1 open to new patients)
• Amblyopia (1 open to new patients)
• Amphetamines (1 open to new patients)
• Anemia (3 open to new patients)
• Anti-NMDA Receptor Encephalitis (1 open to new patients)
• Anti-Synthetase Syndrome (1 open to new patients)
• Apnea of Prematurity (1 open to new patients)
• Attention-Deficit/Hyperactivity Disorder (2 open to new patients)
• Autism (1 open to new patients)
• Autoimmune Disease (1 open to new patients)
• Autoimmune Encephalitis (1 open to new patients)
• Cancer, General (2 open to new patients)
• COVID-19 (1 open to new patients)
• Cystic Fibrosis (1 open to new patients)
• Depression (2 open to new patients)
• Dermatologic Diseases (1 open to new patients)
• Dermatomyositis (1 open to new patients)
• Diffuse Scleroderma (1 open to new patients)
• Encephalitis (1 open to new patients)
• Exercise (1 open to new patients)
• Fabry Disease (1 open to new patients)
• Family Functioning (1 open to new patients)
• Family Members (1 open to new patients)
• Fibrosis (1 open to new patients)
• Ganglioneuroblastoma (1 open to new patients)
• Gaucher Disease (1 open to new patients)
• Glomerulonephritis (1 open to new patients)
• Glucocerebrosidase Deficiency Disease (1 open to new patients)
• Health Care Utilization (1 open to new patients)
• Hemolytic-Uremic Syndrome (1 open to new patients)
• Hepatotoxicity (1 open to new patients)
• Hodgkin's Lymphoma (1 open to new patients)
• IC-MPGN (1 open to new patients)
• Idiopathic Inflammatory Myositis (IIM) (1 open to new patients)
• Immunodeficiency (1 open to new patients)
• Immunotherapy (1 open to new patients)
• Inflammatory Bowel Disease (1 open to new patients)
• Juvenile Dermatomyositis (1 open to new patients)
• Juvenile Myositis (1 open to new patients)
• Juvenile Polymyositis (1 open to new patients)
• Kidney Disease (1 open to new patients)
• Leukemia (1 open to new patients)
• LGMD2A (1 open to new patients)
• Limb-Girdle Muscular Dystrophy (1 open to new patients)
• Lupus (2 open to new patients)
• Lymphoma (4 open to new patients)
• Mental Disorder (2 open to new patients)
• Mental Health (1 open to new patients)
• Metastatic Castration-Resistant Prostate Cancer (1 open to new patients)
• Middle Ear Infection (1 open to new patients)
• Multiple Myeloma (1 open to new patients)
• Myopathy (1 open to new patients)
• Nasopharyngeal Cancer (1 open to new patients)
• Neoplasms (3 open to new patients)
• Neuroblastoma (1 open to new patients)
• Non-Small Cell Lung Cancer (2 open to new patients)
• Obesity (1 open to new patients)
• Pain (1 open to new patients)
• Pigmented Skin Lesion of Uncertain Nature (1 open to new patients)
• Pompe Disease (3 open to new patients)
• Postoperative Pain (1 open to new patients)
• Prader-Willi Syndrome (1 open to new patients)
• Premature Birth (2 open to new patients)
• Primary Immunodeficiency Diseases (1 open to new patients)
• Prostate Cancer (1 open to new patients)
• Psoriasis (1 open to new patients)
• Psychotic Disorders (2 open to new patients)
• Retinopathy of Prematurity (1 open to new patients)
• Schizophrenia (1 open to new patients)
• Seizures (1 open to new patients)
• Sickle Cell Anemia (3 open to new patients)
• Skin Burn Multiple (1 open to new patients)
• Skin Cancer/Melanoma (1 open to new patients)
• Skin Lesion (1 open to new patients)
• Solid Tumor (3 open to new patients)
• Stress (1 open to new patients)
• Stress and Memory (1 open to new patients)
• Suicide (1 open to new patients)
• Systemic Sclerosis (1 open to new patients)
• Ulcerative Colitis (1 open to new patients)